Julia Reichelt
YOU?
Author Swipe
View article: Mutual reinforcement of lymphotoxin-driven myositis and impaired autophagy in murine muscle
Mutual reinforcement of lymphotoxin-driven myositis and impaired autophagy in murine muscle Open
Inclusion body myositis (IBM) is a progressive muscle disorder characterized by inflammation and degeneration with altered proteostasis. To better understand the interrelationship between these two features, we aimed to establish a novel p…
View article: COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa
COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa Open
Background Epidermolysis bullosa (EB), a severe genetic disorder characterized by blister formation in skin, is caused by mutations in genes encoding dermal-epidermal junction proteins that function to hold the skin layers together. CRISPR…
View article: Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa Open
View article: Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer Open
Conventional anti-cancer therapies based on chemo- and/or radiotherapy represent highly effective means to kill cancer cells but lack tumor specificity and, therefore, result in a wide range of iatrogenic effects. A promising approach to o…
View article: Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial
Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial Open
View article: Advancing novel therapies for ichthyoses
Advancing novel therapies for ichthyoses Open
Linked Article: Valentin et al. Br J Dermatol 2021; 184:1123–1131.
View article: Gene expression is stable in a complete CIB1 knockout keratinocyte model
Gene expression is stable in a complete CIB1 knockout keratinocyte model Open
Epidermodysplasia verruciformis (EV) is a genodermatosis characterized by the inability of keratinocytes to control cutaneous β-HPV infection and a high risk for non-melanoma skin cancer (NMSC). Bi-allelic loss of function variants in TMC6…
View article: A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas
A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas Open
Background Cutaneous squamous cell carcinomas (cSCC) are the primary cause of premature deaths in patients suffering from the rare skin-fragility disorder recessive dystrophic epidermolysis bullosa (RDEB), which is in marked contrast to th…
View article: MiRNA-10b marks aggressive squamous cell carcinomas, and confers a cancer stem cell-like phenotype
MiRNA-10b marks aggressive squamous cell carcinomas, and confers a cancer stem cell-like phenotype Open
Background Cutaneous squamous cell carcinomas (cSCC) are the primary cause of premature deaths in patients suffering from the rare skin-fragility disorder recessive dystrophic epidermolysis bullosa, which is in marked contrast to the rarel…
View article: Arginine‐ but not alanine‐rich carboxy‐termini trigger nuclear translocation of mutant keratin 10 in ichthyosis with confetti
Arginine‐ but not alanine‐rich carboxy‐termini trigger nuclear translocation of mutant keratin 10 in ichthyosis with confetti Open
Ichthyosis with confetti (IWC) is a genodermatosis associated with dominant‐negative variants in keratin 10 ( KRT10 ) or keratin 1 ( KRT1 ). These frameshift variants result in extended aberrant proteins, localized to the nucleus rather th…
View article: Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination
Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination Open
Current gene-editing approaches for treatment of recessive dystrophic epidermolysis bullosa (RDEB), an inherited, severe form of blistering skin disease, suffer from low efficiencies and safety concerns that complicate implementation in cl…
View article: Epidermolysis bullosa: Advances in research and treatment
Epidermolysis bullosa: Advances in research and treatment Open
Epidermolysis bullosa (EB) is the umbrella term for a group of rare inherited skin fragility disorders caused by mutations in at least 20 different genes. There is no cure for any of the subtypes of EB resulting from different mutations, a…
View article: Gene Editing–Mediated Disruption of Epidermolytic Ichthyosis–Associated KRT10 Alleles Restores Filament Stability in Keratinocytes
Gene Editing–Mediated Disruption of Epidermolytic Ichthyosis–Associated KRT10 Alleles Restores Filament Stability in Keratinocytes Open
Epidermolytic ichthyosis is a skin fragility disorder caused by dominant-negative mutations in KRT1 or KRT10. No definitive restorative therapies exist that target these genetic faults. Gene editing can be used to efficiently introduce fra…
View article: Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes
Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes Open
View article: An<i>ex vivo</i><scp>RNA</scp><i>trans</i>‐splicing strategy to correct human generalized severe epidermolysis bullosa simplex
An<i>ex vivo</i><span>RNA</span><i>trans</i>‐splicing strategy to correct human generalized severe epidermolysis bullosa simplex Open
Our data demonstrate that trans-splicing-mediated mRNA therapy is an effective method for the correction of dominantly inherited KRT14 mutations at the transcriptional level. This results in the rescue of the EBS-gen sev phenotype and stab…
View article: Reduced Microbial Diversity Is a Feature of Recessive Dystrophic Epidermolysis Bullosa-Involved Skin and Wounds
Reduced Microbial Diversity Is a Feature of Recessive Dystrophic Epidermolysis Bullosa-Involved Skin and Wounds Open
View article: Advances on potential therapeutic options for epidermolysis bullosa
Advances on potential therapeutic options for epidermolysis bullosa Open
Introduction: Epidermolysis bullosa is a severe genodermatosis in which pain and wound management dominate patients’ lives leaving a high demand for more effective treatments. At present, gene therapy is the only treatment with the potenti…
View article: RNA Trans-Splicing Modulation via Antisense Molecule Interference
RNA Trans-Splicing Modulation via Antisense Molecule Interference Open
In recent years, RNA trans-splicing has emerged as a suitable RNA editing tool for the specific replacement of mutated gene regions at the pre-mRNA level. Although the technology has been successfully applied for the restoration of protein…
View article: Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell Carcinoma
Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell Carcinoma Open
Extracellular vesicles (EVs) are cell-derived membrane-bound vesicles that are important mediators of intercellular communication, and critical orchestrators of both physiological and pathologic processes. They are found in various biologi…
View article: Regeneration of the entire human epidermis using transgenic stem cells
Regeneration of the entire human epidermis using transgenic stem cells Open
View article: 189 Improved safety profile: An efficient CRISPR/Cas9 double nicking approach for KRT14 repair in EB simplex
189 Improved safety profile: An efficient CRISPR/Cas9 double nicking approach for KRT14 repair in EB simplex Open
View article: 599 Deregulation of miR-10b affects HOXD10 expression in squamous cell carcinoma from epidermolysis bullosa patients
599 Deregulation of miR-10b affects HOXD10 expression in squamous cell carcinoma from epidermolysis bullosa patients Open
View article: 560 Transcriptome profiling in recessive dystrophic epidermolysis bullosa patients
560 Transcriptome profiling in recessive dystrophic epidermolysis bullosa patients Open
View article: 117 Using a bivalent DNA aptamer to reduce blister formation in recessive dystrophic epidermolysis bullosa
117 Using a bivalent DNA aptamer to reduce blister formation in recessive dystrophic epidermolysis bullosa Open
View article: Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases
Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases Open
With the ability to induce rapid and efficient repair of disease-causing mutations, CRISPR/Cas9 technology is ideally suited for gene therapy approaches for recessively and dominantly inherited monogenic disorders. In this study, we have c…
View article: An RNA-targeted therapy for dystrophic epidermolysis bullosa
An RNA-targeted therapy for dystrophic epidermolysis bullosa Open
Functional impairment or complete loss of type VII collagen, caused by mutations within COL7A1, lead to the severe recessive form of the skin blistering disease dystrophic epidermolysis bullosa (RDEB). Here, we successfully demonstrate RNA…
View article: COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa Open
Designer nucleases allow specific and precise genomic modifications and represent versatile molecular tools for the correction of disease-associated mutations. In this study, we have exploited an ex vivo CRISPR/Cas9-mediated homology-direc…
View article: Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients
Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients Open
View article: 28 Successful gene editing of human embryonic stem cells to generate a novel CF airway epithelial model
28 Successful gene editing of human embryonic stem cells to generate a novel CF airway epithelial model Open
View article: 534 TALEN-mediated gene editing of keratinocyte stem cells for a novel e x vivo epidermolytic ichthyosis therapy
534 TALEN-mediated gene editing of keratinocyte stem cells for a novel e x vivo epidermolytic ichthyosis therapy Open